PUR9_HUMAN - dbPTM
PUR9_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID PUR9_HUMAN
UniProt AC P31939
Protein Name Bifunctional purine biosynthesis protein PURH
Gene Name ATIC
Organism Homo sapiens (Human).
Sequence Length 592
Subcellular Localization
Protein Description Bifunctional enzyme that catalyzes 2 steps in purine biosynthesis.; Promotes insulin receptor/INSR autophosphorylation and is involved in INSR internalization. [PubMed: 25687571]
Protein Sequence MAPGQLALFSVSDKTGLVEFARNLTALGLNLVASGGTAKALRDAGLAVRDVSELTGFPEMLGGRVKTLHPAVHAGILARNIPEDNADMARLDFNLIRVVACNLYPFVKTVASPGVTVEEAVEQIDIGGVTLLRAAAKNHARVTVVCEPEDYVVVSTEMQSSESKDTSLETRRQLALKAFTHTAQYDEAISDYFRKQYSKGVSQMPLRYGMNPHQTPAQLYTLQPKLPITVLNGAPGFINLCDALNAWQLVKELKEALGIPAAASFKHVSPAGAAVGIPLSEDEAKVCMVYDLYKTLTPISAAYARARGADRMSSFGDFVALSDVCDVPTAKIISREVSDGIIAPGYEEEALTILSKKKNGNYCVLQMDQSYKPDENEVRTLFGLHLSQKRNNGVVDKSLFSNVVTKNKDLPESALRDLIVATIAVKYTQSNSVCYAKNGQVIGIGAGQQSRIHCTRLAGDKANYWWLRHHPQVLSMKFKTGVKRAEISNAIDQYVTGTIGEDEDLIKWKALFEEVPELLTEAEKKEWVEKLTEVSISSDAFFPFRDNVDRAKRSGVAYIAAPSGSAADKVVIEACDELGIILAHTNLRLFHH
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
1Acetylation-------MAPGQLAL
-------CCCCCEEE
10.2919413330
9 (in isoform 2)Phosphorylation-5.8825106551
10PhosphorylationPGQLALFSVSDKTGL
CCCEEEEEECCCCCH
22.8925850435
11 (in isoform 2)Phosphorylation-7.2225106551
12PhosphorylationQLALFSVSDKTGLVE
CEEEEEECCCCCHHH
31.9925850435
14UbiquitinationALFSVSDKTGLVEFA
EEEEECCCCCHHHHH
36.6721890473
25PhosphorylationVEFARNLTALGLNLV
HHHHHHHHHHCCEEE
24.3220068231
34PhosphorylationLGLNLVASGGTAKAL
HCCEEEECCHHHHHH
30.2120068231
37PhosphorylationNLVASGGTAKALRDA
EEEECCHHHHHHHHC
28.6320068231
38UbiquitinationLVASGGTAKALRDAG
EEECCHHHHHHHHCC
9.8221890473
38UbiquitinationLVASGGTAKALRDAG
EEECCHHHHHHHHCC
9.8221906983
39AcetylationVASGGTAKALRDAGL
EECCHHHHHHHHCCC
48.0325953088
39UbiquitinationVASGGTAKALRDAGL
EECCHHHHHHHHCCC
48.0321890473
42MethylationGGTAKALRDAGLAVR
CHHHHHHHHCCCCCC
36.27-
52PhosphorylationGLAVRDVSELTGFPE
CCCCCCHHHHHCCHH
31.0421712546
60SulfoxidationELTGFPEMLGGRVKT
HHHCCHHHHCCCCCC
4.2521406390
65UbiquitinationPEMLGGRVKTLHPAV
HHHHCCCCCCCCHHH
6.6721890473
65UbiquitinationPEMLGGRVKTLHPAV
HHHHCCCCCCCCHHH
6.6721906983
66MalonylationEMLGGRVKTLHPAVH
HHHCCCCCCCCHHHH
43.9726320211
66UbiquitinationEMLGGRVKTLHPAVH
HHHCCCCCCCCHHHH
43.9721890473
67PhosphorylationMLGGRVKTLHPAVHA
HHCCCCCCCCHHHHH
27.6928857561
79MethylationVHAGILARNIPEDNA
HHHHHHHCCCCCCCC
37.86-
101GlutathionylationNLIRVVACNLYPFVK
HHHHHHHCCCHHHHC
2.1422555962
104PhosphorylationRVVACNLYPFVKTVA
HHHHCCCHHHHCCCC
4.8021082442
108UbiquitinationCNLYPFVKTVASPGV
CCCHHHHCCCCCCCC
37.35-
109PhosphorylationNLYPFVKTVASPGVT
CCHHHHCCCCCCCCC
18.9228450419
112PhosphorylationPFVKTVASPGVTVEE
HHHCCCCCCCCCHHH
20.1829496963
116PhosphorylationTVASPGVTVEEAVEQ
CCCCCCCCHHHHHHH
28.2830087585
137UbiquitinationTLLRAAAKNHARVTV
HHHHHHHHCCCEEEE
44.53-
146GlutathionylationHARVTVVCEPEDYVV
CCEEEEEECCCCEEE
6.6722555962
158SulfoxidationYVVVSTEMQSSESKD
EEEEEEECCCCCCCC
4.7930846556
160PhosphorylationVVSTEMQSSESKDTS
EEEEECCCCCCCCCC
34.4620068231
161PhosphorylationVSTEMQSSESKDTSL
EEEECCCCCCCCCCH
29.0620068231
163PhosphorylationTEMQSSESKDTSLET
EECCCCCCCCCCHHH
37.4720068231
166PhosphorylationQSSESKDTSLETRRQ
CCCCCCCCCHHHHHH
38.66-
176UbiquitinationETRRQLALKAFTHTA
HHHHHHHHHHHHHHH
5.8221890473
176UbiquitinationETRRQLALKAFTHTA
HHHHHHHHHHHHHHH
5.8221906983
177UbiquitinationTRRQLALKAFTHTAQ
HHHHHHHHHHHHHHH
35.5321906983
180PhosphorylationQLALKAFTHTAQYDE
HHHHHHHHHHHHHHH
24.15-
182PhosphorylationALKAFTHTAQYDEAI
HHHHHHHHHHHHHHH
16.64-
190PhosphorylationAQYDEAISDYFRKQY
HHHHHHHHHHHHHHH
33.0528152594
192PhosphorylationYDEAISDYFRKQYSK
HHHHHHHHHHHHHCC
9.8628152594
197PhosphorylationSDYFRKQYSKGVSQM
HHHHHHHHCCCCCCC
18.5122817900
198UbiquitinationDYFRKQYSKGVSQMP
HHHHHHHCCCCCCCC
22.0521890473
198UbiquitinationDYFRKQYSKGVSQMP
HHHHHHHCCCCCCCC
22.0521906983
199AcetylationYFRKQYSKGVSQMPL
HHHHHHCCCCCCCCC
59.4019608861
199UbiquitinationYFRKQYSKGVSQMPL
HHHHHHCCCCCCCCC
59.4021890473
202PhosphorylationKQYSKGVSQMPLRYG
HHHCCCCCCCCCCCC
29.4528857561
204SulfoxidationYSKGVSQMPLRYGMN
HCCCCCCCCCCCCCC
2.3521406390
208PhosphorylationVSQMPLRYGMNPHQT
CCCCCCCCCCCCCCC
28.5421945579
215PhosphorylationYGMNPHQTPAQLYTL
CCCCCCCCHHHEEEC
19.9821945579
220PhosphorylationHQTPAQLYTLQPKLP
CCCHHHEEECCCCCC
8.0421945579
221PhosphorylationQTPAQLYTLQPKLPI
CCHHHEEECCCCCCE
27.7521945579
241S-palmitoylationAPGFINLCDALNAWQ
CCCHHHHHHHHCHHH
2.1929575903
253UbiquitinationAWQLVKELKEALGIP
HHHHHHHHHHHHCCC
5.14-
254UbiquitinationWQLVKELKEALGIPA
HHHHHHHHHHHCCCC
41.87-
264PhosphorylationLGIPAAASFKHVSPA
HCCCCHHCCCCCCCC
30.0530108239
265AcetylationGIPAAASFKHVSPAG
CCCCHHCCCCCCCCC
5.63-
265UbiquitinationGIPAAASFKHVSPAG
CCCCHHCCCCCCCCC
5.63-
266AcetylationIPAAASFKHVSPAGA
CCCHHCCCCCCCCCC
40.3723954790
266MalonylationIPAAASFKHVSPAGA
CCCHHCCCCCCCCCC
40.3726320211
266UbiquitinationIPAAASFKHVSPAGA
CCCHHCCCCCCCCCC
40.37-
269PhosphorylationAASFKHVSPAGAAVG
HHCCCCCCCCCCEEC
14.5727067055
280PhosphorylationAAVGIPLSEDEAKVC
CEECCCCCHHHHHHH
37.3328450419
284UbiquitinationIPLSEDEAKVCMVYD
CCCCHHHHHHHHHHH
23.15-
285UbiquitinationPLSEDEAKVCMVYDL
CCCHHHHHHHHHHHH
33.64-
287GlutathionylationSEDEAKVCMVYDLYK
CHHHHHHHHHHHHHH
1.1822555962
287S-palmitoylationSEDEAKVCMVYDLYK
CHHHHHHHHHHHHHH
1.1826865113
290PhosphorylationEAKVCMVYDLYKTLT
HHHHHHHHHHHHHCC
3.5520090780
293UbiquitinationVCMVYDLYKTLTPIS
HHHHHHHHHHCCHHH
10.07-
293PhosphorylationVCMVYDLYKTLTPIS
HHHHHHHHHHCCHHH
10.0727259358
294UbiquitinationCMVYDLYKTLTPISA
HHHHHHHHHCCHHHH
44.34-
295PhosphorylationMVYDLYKTLTPISAA
HHHHHHHHCCHHHHH
23.4719835603
297PhosphorylationYDLYKTLTPISAAYA
HHHHHHCCHHHHHHH
24.6520873877
300PhosphorylationYKTLTPISAAYARAR
HHHCCHHHHHHHHHC
14.1928152594
303PhosphorylationLTPISAAYARARGAD
CCHHHHHHHHHCCCC
9.0628152594
305MethylationPISAAYARARGADRM
HHHHHHHHHCCCCCC
16.49-
312SulfoxidationRARGADRMSSFGDFV
HHCCCCCCCCCCCCC
3.9621406390
313PhosphorylationARGADRMSSFGDFVA
HCCCCCCCCCCCCCH
24.3328348404
314PhosphorylationRGADRMSSFGDFVAL
CCCCCCCCCCCCCHH
24.7328348404
325GlutathionylationFVALSDVCDVPTAKI
CCHHHHCCCCCCCEE
5.3922555962
330UbiquitinationDVCDVPTAKIISREV
HCCCCCCCEEEEEEC
8.59-
331AcetylationVCDVPTAKIISREVS
CCCCCCCEEEEEECC
42.9525953088
331UbiquitinationVCDVPTAKIISREVS
CCCCCCCEEEEEECC
42.9521890473
338PhosphorylationKIISREVSDGIIAPG
EEEEEECCCCCCCCC
25.9320873877
346PhosphorylationDGIIAPGYEEEALTI
CCCCCCCCHHHHHHH
21.0720873877
355UbiquitinationEEALTILSKKKNGNY
HHHHHHHEECCCCCE
38.2821890473
355AcetylationEEALTILSKKKNGNY
HHHHHHHEECCCCCE
38.28-
355UbiquitinationEEALTILSKKKNGNY
HHHHHHHEECCCCCE
38.2821906983
355PhosphorylationEEALTILSKKKNGNY
HHHHHHHEECCCCCE
38.2821712546
356UbiquitinationEALTILSKKKNGNYC
HHHHHHEECCCCCEE
65.41-
356AcetylationEALTILSKKKNGNYC
HHHHHHEECCCCCEE
65.4123954790
356UbiquitinationEALTILSKKKNGNYC
HHHHHHEECCCCCEE
65.4121890473
357UbiquitinationALTILSKKKNGNYCV
HHHHHEECCCCCEEE
48.36-
357AcetylationALTILSKKKNGNYCV
HHHHHEECCCCCEEE
48.3625953088
357UbiquitinationALTILSKKKNGNYCV
HHHHHEECCCCCEEE
48.36-
358MalonylationLTILSKKKNGNYCVL
HHHHEECCCCCEEEE
74.0532601280
358UbiquitinationLTILSKKKNGNYCVL
HHHHEECCCCCEEEE
74.05-
370PhosphorylationCVLQMDQSYKPDENE
EEEEECCCCCCCHHH
30.7520873877
371UbiquitinationVLQMDQSYKPDENEV
EEEECCCCCCCHHHH
22.40-
371PhosphorylationVLQMDQSYKPDENEV
EEEECCCCCCCHHHH
22.4020873877
372UbiquitinationLQMDQSYKPDENEVR
EEECCCCCCCHHHHH
51.76-
380PhosphorylationPDENEVRTLFGLHLS
CCHHHHHHHHHHHHC
31.4520873877
387PhosphorylationTLFGLHLSQKRNNGV
HHHHHHHCCCCCCCC
23.9428450419
388UbiquitinationLFGLHLSQKRNNGVV
HHHHHHCCCCCCCCC
55.9021890473
388UbiquitinationLFGLHLSQKRNNGVV
HHHHHHCCCCCCCCC
55.9021906983
3892-HydroxyisobutyrylationFGLHLSQKRNNGVVD
HHHHHCCCCCCCCCC
54.43-
389AcetylationFGLHLSQKRNNGVVD
HHHHHCCCCCCCCCC
54.4325953088
389UbiquitinationFGLHLSQKRNNGVVD
HHHHHCCCCCCCCCC
54.4321890473
396UbiquitinationKRNNGVVDKSLFSNV
CCCCCCCCHHHHHCC
32.2121890473
396UbiquitinationKRNNGVVDKSLFSNV
CCCCCCCCHHHHHCC
32.2121906983
397AcetylationRNNGVVDKSLFSNVV
CCCCCCCHHHHHCCC
37.1325953088
397UbiquitinationRNNGVVDKSLFSNVV
CCCCCCCHHHHHCCC
37.1321890473
398PhosphorylationNNGVVDKSLFSNVVT
CCCCCCHHHHHCCCC
30.1320873877
401PhosphorylationVVDKSLFSNVVTKNK
CCCHHHHHCCCCCCC
33.7320068231
405UbiquitinationSLFSNVVTKNKDLPE
HHHHCCCCCCCCCCH
25.3121890473
405UbiquitinationSLFSNVVTKNKDLPE
HHHHCCCCCCCCCCH
25.3121906983
405PhosphorylationSLFSNVVTKNKDLPE
HHHHCCCCCCCCCCH
25.3120068231
406AcetylationLFSNVVTKNKDLPES
HHHCCCCCCCCCCHH
50.8425953088
406UbiquitinationLFSNVVTKNKDLPES
HHHCCCCCCCCCCHH
50.8421890473
407UbiquitinationFSNVVTKNKDLPESA
HHCCCCCCCCCCHHH
33.44-
408UbiquitinationSNVVTKNKDLPESAL
HCCCCCCCCCCHHHH
63.30-
413PhosphorylationKNKDLPESALRDLIV
CCCCCCHHHHHHHHH
30.57-
422PhosphorylationLRDLIVATIAVKYTQ
HHHHHHHHHEEEECC
9.8924667141
427PhosphorylationVATIAVKYTQSNSVC
HHHHEEEECCCCCEE
11.9228152594
428PhosphorylationATIAVKYTQSNSVCY
HHHEEEECCCCCEEE
21.5828152594
430PhosphorylationIAVKYTQSNSVCYAK
HEEEECCCCCEEEEE
24.2328152594
432PhosphorylationVKYTQSNSVCYAKNG
EEECCCCCEEEEECC
20.8628857561
434S-nitrosocysteineYTQSNSVCYAKNGQV
ECCCCCEEEEECCEE
2.47-
434S-nitrosylationYTQSNSVCYAKNGQV
ECCCCCEEEEECCEE
2.4719483679
435PhosphorylationTQSNSVCYAKNGQVI
CCCCCEEEEECCEEE
20.6028152594
436UbiquitinationQSNSVCYAKNGQVIG
CCCCEEEEECCEEEE
8.16-
437AcetylationSNSVCYAKNGQVIGI
CCCEEEEECCEEEEE
34.8326051181
437UbiquitinationSNSVCYAKNGQVIGI
CCCEEEEECCEEEEE
34.83-
450PhosphorylationGIGAGQQSRIHCTRL
EECCCCCCEEEEEEE
25.8928857561
460UbiquitinationHCTRLAGDKANYWWL
EEEEECCCCCCCHHH
41.09-
461AcetylationCTRLAGDKANYWWLR
EEEECCCCCCCHHHH
37.3025953088
461UbiquitinationCTRLAGDKANYWWLR
EEEECCCCCCCHHHH
37.30-
464PhosphorylationLAGDKANYWWLRHHP
ECCCCCCCHHHHCCH
11.6528152594
475PhosphorylationRHHPQVLSMKFKTGV
HCCHHHEEEEECCCC
22.5228857561
476UbiquitinationHHPQVLSMKFKTGVK
CCHHHEEEEECCCCC
5.31-
477AcetylationHPQVLSMKFKTGVKR
CHHHEEEEECCCCCH
40.0925953088
477UbiquitinationHPQVLSMKFKTGVKR
CHHHEEEEECCCCCH
40.09-
506UbiquitinationIGEDEDLIKWKALFE
CCCCHHHHHHHHHHH
8.49-
507AcetylationGEDEDLIKWKALFEE
CCCHHHHHHHHHHHH
50.3625953088
507SumoylationGEDEDLIKWKALFEE
CCCHHHHHHHHHHHH
50.36-
507UbiquitinationGEDEDLIKWKALFEE
CCCHHHHHHHHHHHH
50.3621906983
508UbiquitinationEDEDLIKWKALFEEV
CCHHHHHHHHHHHHH
5.55-
509SumoylationDEDLIKWKALFEEVP
CHHHHHHHHHHHHHH
30.15-
509UbiquitinationDEDLIKWKALFEEVP
CHHHHHHHHHHHHHH
30.1520639865
520PhosphorylationEEVPELLTEAEKKEW
HHHHHHHHHHHHHHH
45.86-
523UbiquitinationPELLTEAEKKEWVEK
HHHHHHHHHHHHHHH
59.43-
524UbiquitinationELLTEAEKKEWVEKL
HHHHHHHHHHHHHHH
64.14-
5242-HydroxyisobutyrylationELLTEAEKKEWVEKL
HHHHHHHHHHHHHHH
64.14-
524UbiquitinationELLTEAEKKEWVEKL
HHHHHHHHHHHHHHH
64.142190698
525UbiquitinationLLTEAEKKEWVEKLT
HHHHHHHHHHHHHHH
48.60-
529UbiquitinationAEKKEWVEKLTEVSI
HHHHHHHHHHHCCEE
43.34-
530UbiquitinationEKKEWVEKLTEVSIS
HHHHHHHHHHCCEEC
51.60-
532PhosphorylationKEWVEKLTEVSISSD
HHHHHHHHCCEECCC
45.4620873877
535PhosphorylationVEKLTEVSISSDAFF
HHHHHCCEECCCCCC
15.5528857561
537PhosphorylationKLTEVSISSDAFFPF
HHHCCEECCCCCCCC
18.0520873877
538PhosphorylationLTEVSISSDAFFPFR
HHCCEECCCCCCCCC
31.1520873877
554PhosphorylationNVDRAKRSGVAYIAA
CHHHHHHCCCEEEEC
36.5921406692
558PhosphorylationAKRSGVAYIAAPSGS
HHHCCCEEEECCCCC
6.6721406692
563PhosphorylationVAYIAAPSGSAADKV
CEEEECCCCCCHHHH
40.4225159151
565PhosphorylationYIAAPSGSAADKVVI
EEECCCCCCHHHHHH
25.3125159151

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
104YPhosphorylationKinaseALKQ9UM73
PSP

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of PUR9_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of PUR9_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
JAK1_HUMANJAK1physical
17353931
RADIL_HUMANRADILphysical
17353931
STOM_HUMANSTOMphysical
17353931
HNRDL_HUMANHNRNPDLphysical
17353931
SNRPA_HUMANSNRPAphysical
17353931
CIA30_HUMANNDUFAF1physical
17353931
CMBL_HUMANCMBLphysical
17353931
TYSY_HUMANTYMSphysical
22939629
SCOT1_HUMANOXCT1physical
22939629
RBBP6_HUMANRBBP6physical
22939629
TADBP_HUMANTARDBPphysical
22939629
SUMO2_HUMANSUMO2physical
22939629
THIO_HUMANTXNphysical
22939629
ASB6_HUMANASB6physical
22863883
IPO5_HUMANIPO5physical
22863883
ISOC1_HUMANISOC1physical
22863883
MOES_HUMANMSNphysical
22863883
ULA1_HUMANNAE1physical
22863883
NSF1C_HUMANNSFL1Cphysical
22863883
LIS1_HUMANPAFAH1B1physical
22863883
PLPHP_HUMANPROSCphysical
22863883
1433E_HUMANYWHAEphysical
22863883
A16A1_HUMANALDH16A1physical
26344197
EF2_HUMANEEF2physical
26344197
RNZ2_HUMANELAC2physical
26344197
PUR2_HUMANGARTphysical
26344197
RTN4_HUMANRTN4physical
26344197
TRNT1_HUMANTRNT1physical
26344197

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
608688AICAR transformylase/IMP cyclohydrolase deficiency (AICAR)
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
DB00563Methotrexate
DB00642Pemetrexed
DB00116Tetrahydrofolic acid
Regulatory Network of PUR9_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND MASS SPECTROMETRY.
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-199, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer.";
Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.;
Cell 131:1190-1203(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-104, AND MASSSPECTROMETRY.

TOP